Xpect Triple Antibiotic Ointment
Product Images NDC 42961-222

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Xpect Triple Antibiotic (NDC 42961-222). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cintas Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Box-10 (Box 10)

FDA Label Image

Box-144 (Box 144)

Box-144 (Box 144)
This text appears to be a list of antibiotic medications including Triple e, Triple Antibiotic, AaTAGN, Neomycn, and Xpect. However, the text quality is poor due to scanning errors and it is not clear what the intended use or context of the medications is.*
FDA Label Image

Box-20 (Box 20)

Box-20 (Box 20)
This is a description of TRIPLE 2, an antiseptic ointment used to prevent infection in minor cuts and burns. The ointment contains Bacitracin, Neomycin, and Polymyxin B. Each packet of the ointment weighs 0.141 oz (0.75), and each box contains 20 packets. The product is distributed by CINTAS in Mason, OH and its product number is 100019. The text also includes information about Xpect First, but it is not clear how it relates to TRIPLE 2.*
FDA Label Image

Packet (Packet)

Packet (Packet)
This is a description of a triple antibiotic ointment containing Bacitracin, Neomycin, and Polymyxin-B in Zinc units. It has 103.5mg of Neomycin and is used as a first aid antibiotic to prevent infection in minor cuts, scrapes, and burns.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.